Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behçet's Disease: A Case Series

Antonio Vitale, Donato Rigante, Francesco Caso, Maria Giuseppina Brizi, Mauro Galeazzi, Luisa Costa, Rossella Franceschini, Orso Maria Lucherini, Luca Cantarini
  • Dermatology, January 2014, Karger Publishers
  • DOI: 10.1159/000358125

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1159/000358125

The following have contributed to this page: Luca Cantarini

In partnership with: